ARTICLE | Company News
FDA accepts Zegerid capsules NDA
June 29, 2005 1:03 AM UTC
FDA accepted for filing an NDA from Santarus (SNTS) for 20 and 40 mg Zegerid omeprazole capsules to treat the symptoms of gastroesophageal reflux disease (GERD), erosive esophagitis, duodenal ulcers a...